Xin Luan
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced biosensing and bioanalysis techniques 11
- Ubiquitin and proteasome pathways 9
-
- Nanoplatforms for cancer theranostics 25
- Co-authors
- Duxin Sun (8 shared papers)Hebao Yuan (5 shared papers)Kanokwan Sansanaphongpricha (3 shared papers)Hongwei Chen (2 shared papers)Hongzhuan Chen (52 shared papers)Hong Zhang (23 shared papers)Ying‐Yun Guan (23 shared papers)Lijun Zhang (28 shared papers)
- Journals
- Biomaterials (7 papers)Advanced Science (6 papers)Phytomedicine (6 papers)Small (5 papers)Environmental Science Nano (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xin Luan
154 papers receiving 5.0k citations
Xin Luan's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 849
- Biomaterials 630
- Complementary and alternative medicine 354
- Molecular Biology 2.8k
- Pharmacology 323
Countries citing papers authored by Xin Luan
This map shows the geographic impact of Xin Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Luan more than expected).
Fields of papers citing papers by Xin Luan
This network shows the impact of papers produced by Xin Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Luan. The network helps show where Xin Luan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Luan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineering exosomes as refined biological nanoplatforms for drug delivery Hit paper breakdown → | 2017 | 951 |
| 2 | Isorhamnetin: A review of pharmacological effects Hit paper breakdown → | 2020 | 372 |
| 3 | Exercise as a prescription for patients with various diseases Hit paper breakdown → | 2019 | 284 |
| 4 | Targeting KRAS mutant cancers: from druggable therapy to drug resistance Hit paper breakdown → | 2022 | 136 |
| 5 | 2020 | 128 | |
| 6 | 2021 | 113 | |
| 7 | 2020 | 108 | |
| 8 | 2020 | 108 | |
| 9 | 2020 | 102 | |
| 10 | 2020 | 100 | |
| 11 | 2020 | 88 | |
| 12 | 2020 | 82 | |
| 13 | 2013 | 74 | |
| 14 | 2020 | 74 | |
| 15 | 2021 | 69 | |
| 16 | 2021 | 61 | |
| 17 | 2016 | 56 | |
| 18 | 2014 | 54 | |
| 19 | 2021 | 53 | |
| 20 | 2014 | 53 |
About Xin Luan
Xin Luan is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Biomaterials and Immunology, having authored 165 papers that have together received 5.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (15 papers), Advanced biosensing and bioanalysis techniques (11 papers), Immunotherapy and Immune Responses (11 papers), Advanced Nanomaterials in Catalysis (9 papers), Peptidase Inhibition and Analysis (9 papers), Ubiquitin and proteasome pathways (9 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (849 citations), Biomaterials (630 citations), Complementary and alternative medicine (354 citations), Molecular Biology (2.8k citations) and Pharmacology (323 citations). Xin Luan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Duxin Sun, Hebao Yuan, Kanokwan Sansanaphongpricha, Hongwei Chen, Hongzhuan Chen, Hong Zhang, Ying‐Yun Guan, Lijun Zhang, Ye Wu and Khalid Rahman. Their work appears in journals such as Biomaterials, Advanced Science, Phytomedicine, Small and Environmental Science Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.